Acadia Pharmaceuticals Overview
Acadia Pharmaceuticals Target Price
Analysts' 12-month price predictions for ACAD.
Share Price
$22.12
Average Target Price
$26.00
17.5% upside
17.5% upside5 analysts in the last 4 months
High: $32 | Low: $22
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-06-26 | OppenheimerMatthew Hershenhorn | $22 |  0.5% downside |  |
| 2025-05-20 | Morgan StanleySean Laaman | $24 | 8.5% upside | |
| 2025-05-19 | NeedhamAmi Fadia | $30 | 35.6% upside | |
| 2025-05-19 | H.C. WainwrightAndrew Fein | $32 | 44.7% upside | |
| 2025-04-28 | UBS | $22 | 0.5% downside | |
| 2025-01-03 | GuggenheimYatin Suneja | $20 | 9.6% downside | |
| 2024-08-07 | Morgan StanleyJeffrey Hung | $20 | 9.6% downside | |
| 2024-06-26 | BMO CapitalKeith Tapper | $31 | 40.1% upside | |
| 2024-05-09 | H.C. WainwrightAndrew Fein | $27 | 22.1% upside | |
| 2024-05-09 | Robert W. BairdJoel Beatty | $28 | 26.6% upside | |
| 2024-05-09 | Mizuho SecuritiesUy Ear | $21 | 5.1% downside | |
| 2024-04-30 | UBSAshwani Verma | $27 | 22.1% upside | |
| 2024-03-12 | UBSAshwani Verma | $33 | 49.2% upside | |
| 2024-03-12 | OppenheimerJay Olson | $19 | 14.1% downside | |
| 2024-03-12 | NeedhamAmi Fadia | $32 | 44.7% upside | |
| 2024-03-12 | Canaccord GenuitySumant Kulkami | $33 | 49.2% upside | |
| 2024-03-12 | JMP SecuritiesJason Butler | $39 | 76.3% upside | |
| 2024-01-24 | NeedhamAmi Fadia | $37 | 67.3% upside | |
| 2022-11-14 | J.P. Morgan | $17 | 23.1% downside | |
| 2022-08-09 | Morgan Stanley | $18 | 18.6% downside | |
| 2022-08-09 | Mizuho Securities | $19 | 14.1% downside | |
| 2022-08-09 | Goldman Sachs | $15 | 32.2% downside | |
| 2022-08-09 | RBC Capital | $21 | 5.1% downside | |
| 2022-08-09 | H.C. Wainwright | $25 | 13% upside | |
| 2022-08-09 | Leerink Partners | $21 | 5.1% downside | |
| 2022-08-08 | Cowen & Co. | $21 | 5.1% downside | |
| 2022-07-15 | Morgan Stanley | $22 | 0.5% downside | |
| 2022-07-11 | Leerink Partners | $27 | 22.1% upside | |
| 2022-06-22 | Citigroup | $19 | 14.1% downside | |
| 2022-06-21 | Oppenheimer | $19 | 14.1% downside | |
| 2022-06-21 | Cantor Fitzgerald | $26 | 17.5% upside | |
| 2022-06-21 | RBC Capital | $26 | 17.5% upside | |
| 2022-06-21 | H.C. Wainwright | $20 | 9.6% downside | |
| 2022-04-19 | Mizuho Securities | $27 | 22.1% upside | |
| 2022-03-20 | Canaccord GenuitySumant Kulkami | $31 | 40.1% upside | |
| 2022-03-01 | Stifel NicolausPaul Matteis | $20 | 9.6% downside | |
| 2022-03-01 | H.C. WainwrightAndrew Fein | $36 | 62.7% upside | |
| 2022-03-01 | Bank of America SecuritiesTazeen Ahmad | $31 | 40.1% upside | |
| 2022-03-01 | CitigroupNeena Bitritto-Garg | $32 | 44.7% upside | |
| 2022-02-28 | Leerink PartnersMarc Goodman | $31 | 40.1% upside | |
| 2021-12-21 | Cowen & Co.Ritu Baral | $32 | 44.7% upside | |
| 2021-12-21 | GuggenheimYatin Suneja | $28 | 26.6% upside | |
| 2021-12-07 | OppenheimerJay Olson | $23 | 4% upside | |
| 2021-08-04 | J.P. MorganCory Kasimov | $34 | 53.7% upside | |
| 2021-04-19 | Deutsche BankPito Chickering | $62 | 180.3% upside | |